Elevated newborn serum immunoreactive trypsinogen associated with a congenital pancreatic cyst

Congenital abdominal cysts have a broad differential diagnosis. Pancreatic cysts are rare lesions that offer a diagnostic and surgical challenge to surgeons. We report on a case of a large left upper quadrant cyst detected in utero, which remained of unclear etiology despite cross-sectional imaging...

Full description

Bibliographic Details
Main Authors: Fabio Botelho, Amanda Hall, Hussein Wissanji
Format: Article
Language:English
Published: Elsevier 2021-10-01
Series:Journal of Pediatric Surgery Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213576621002074
Description
Summary:Congenital abdominal cysts have a broad differential diagnosis. Pancreatic cysts are rare lesions that offer a diagnostic and surgical challenge to surgeons. We report on a case of a large left upper quadrant cyst detected in utero, which remained of unclear etiology despite cross-sectional imaging at birth. Intraoperative findings confirmed its pancreatic origin. In hindsight, a pre-operative elevated immunoreactive trypsinogen, performed as part of universal cystic fibrosis (CF) newborn screening, may have suggested the diagnosis.False-positive CF screening tests may be unnoticed by a surgical team assessing infants with an abdominal mass. As universal testing for cystic fibrosis increases in Canada and worldwide, physicians should review a patient's CF screening history. Elevated immunoreactive trypsinogen levels with normal sweat chloride and cystic fibrosis transmembrane conductance regulator (CFTR) detection tests may orient towards a pancreatic etiology when assessing a patient with a congenital abdominal cyst of unclear etiology.
ISSN:2213-5766